These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3064027)

  • 1. Spontaneous or carcinogen-mediated amplification of a mutated ras gene promotes neoplastic transformation.
    Sorrentino V; McKinney MD; Drozdoff V; Hume CR; Fleissner E
    Oncogene Res; 1988; 2(2):189-95. PubMed ID: 3064027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
    Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
    Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
    Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
    Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EJ/ras neoplastic transformation of simian virus 40-immortalized human uroepithelial cells: a rare event.
    Christian BJ; Kao CH; Wu SQ; Meisner LF; Reznikoff CA
    Cancer Res; 1990 Aug; 50(15):4779-86. PubMed ID: 2164447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesion of Kirsten-ras+ tumor-progressing and Kirsten-ras- revertant 3T3 cells on fibronectin proteolytic fragments.
    Radinsky R; Flickinger KS; Kosir MA; Zardi L; Culp LA
    Cancer Res; 1990 Jul; 50(14):4388-400. PubMed ID: 2163749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive overexpression of a 89 kDa heat shock protein gene in the HBL100 human mammary cell line converted to a tumorigenic phenotype by the EJ/T24 Harvey-ras oncogene.
    Lebeau J; Le Chalony C; Prosperi MT; Goubin G
    Oncogene; 1991 Jul; 6(7):1125-32. PubMed ID: 1861862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of the neoplastic phenotype of EBV-established B lymphocytes by the human Ha-ras oncogene.
    Nasi S; Sirinian MI; Panetta G; Marchetti A; Jucker R
    Oncogene; 1990 Jan; 5(1):117-22. PubMed ID: 2157177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogene-mediated multistep transformation of C3H10T1/2 cells.
    Taparowsky EJ; Heaney ML; Parsons JT
    Cancer Res; 1987 Aug; 47(15):4125-9. PubMed ID: 3300959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ras-induced neoplastic transformation and sensitivity to tumor necrosis factor.
    Fernandez A; Chen PW; Ananthaswamy HN
    Anticancer Res; 1994; 14(6B):2649-52. PubMed ID: 7872696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased resistance to cis-diamminedichloroplatinum(II) in NIH 3T3 cells transformed by ras oncogenes.
    Sklar MD
    Cancer Res; 1988 Feb; 48(4):793-7. PubMed ID: 3276398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid cell transformation requires the expression of the HMGA1 proteins.
    Berlingieri MT; Pierantoni GM; Giancotti V; Santoro M; Fusco A
    Oncogene; 2002 May; 21(19):2971-80. PubMed ID: 12082527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts.
    Kivinen L; Pitkänen K; Laiho M
    Oncogene; 1993 Oct; 8(10):2703-11. PubMed ID: 8378082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting morphological changes in PC12 flat cells expressing two different forms of exogenous oncogenic ras.
    Rozenberg YY; Howard BD
    Exp Cell Res; 1994 Mar; 211(1):59-67. PubMed ID: 8125159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of lethal mutations is suppressed in neoplastically transformed cells and after treatment of normal cells with carcinogens.
    Mothersill C; Lyng F; O'Reilly S; Harney J; Seymour CB
    Radiat Res; 1996 Jun; 145(6):714-21. PubMed ID: 8643831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of the Ect2 proto-oncogene and over-expression of Ect2 mRNA and protein in nickel compound and methylcholanthrene-transformed 10T1/2 mouse fibroblast cell lines.
    Clemens F; Verma R; Ramnath J; Landolph JR
    Toxicol Appl Pharmacol; 2005 Aug; 206(2):138-49. PubMed ID: 15967202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell.
    Muschel RJ; Williams JE; Lowy DR; Liotta LA
    Am J Pathol; 1985 Oct; 121(1):1-8. PubMed ID: 3901774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant transformation of human fibroblasts by oncogene transfection or carcinogen treatment.
    McCormick JJ; Fry DG; Hurlin PJ; Morgan TL; Wilson DM; Maher VM
    Prog Clin Biol Res; 1990; 340D():195-205. PubMed ID: 2196579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal diversity of the Kirsten-ras oncogene during tumor progression in athymic nude mice: mechanisms of amplification and rearrangement.
    Radinsky R; Kraemer PM; Proffitt MR; Culp LA
    Cancer Res; 1988 Sep; 48(17):4941-53. PubMed ID: 3409227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoplastic transformation of human cells in vitro.
    Rhim JS
    Crit Rev Oncog; 1993; 4(3):313-35. PubMed ID: 8485202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of the metastatic phenotype of a mouse skin carcinoma cell line independent of E-cadherin expression and correlated with reduced Ha-ras oncogene products.
    Caulín C; López-Barcons L; Gonzáles-Garrigues M; Navarro P; Lozano E; Rodrigo I; Gamallo C; Cano A; Fabra A; Quintanilla M
    Mol Carcinog; 1996 Feb; 15(2):104-14. PubMed ID: 8599577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.